More Countries Prepare Action Plans
The World Health Organization (WHO) has raised concerns about the growing threat of antimicrobial resistance (AMR), warning that many patients worldwide still lack access to proper diagnostic testing and effective treatment. The latest findings, highlight the need for stronger healthcare systems to tackle drug-resistant infections.
According to WHO data, 173 countries have now developed national plans to address antimicrobial resistance, compared with just 79 countries in 2017. However, having a strategy in place does not necessarily mean that patients are receiving adequate protection.
One in Six Bacterial Infections Shows Resistance
The report highlights that approximately one in six laboratory-confirmed bacterial infections worldwide was resistant to antibiotics in 2023. This makes several common infections increasingly difficult to treat and can also create additional risks during surgeries, childbirth and cancer treatment.
WHO also found that only 22% of countries have both the required funding and fully implemented national action plans to tackle the problem.
Testing and Treatment Remain Major Challenges
Access to laboratory testing remains a significant concern. Only 36% of countries reported having national reference laboratories equipped to test selected bacteria and fungi for drug resistance.
The organisation is urging governments to strengthen infection prevention, improve diagnostic facilities and ensure that patients receive appropriate treatment. Greater awareness about the responsible use of antibiotics is also considered essential to prevent resistance from spreading further.
The findings underline the importance of coordinated global action to protect the effectiveness of medicines and make future treatments more reliable.
